PATRICIA M. DANZON

Patricia Danzon is the Celia Moh Professor Emeritus at The Wharton School, University of Pennsylvania. Professor Danzon received a B.A. from Oxford University, England, and a Ph.D. in Economics from the University of Chicago. She previously held faculty positions at Duke University and the University of Chicago. Professor Danzon is an internationally recognized expert in the fields of economics of health care, the biopharmaceutical industry, and insurance.  She is a member of the National Academy of Medicine and the National Academy of Social Insurance, and a Research Associate at the National Bureau of Economic Research. She has served as a consultant to many governmental agencies, NGOs and private corporations in the US and internationally. Professor Danzon has served on the Board of Directors of Medarex, Inc., the Policy and Global Affairs Board of the National Academy of Sciences, and the Policy Board of the Office of Health Economics in London.

Professor Danzon has been an Associate Editor of the American Economic Review, the Journal of Health Economics and the International Journal of Health Care Finance and Economics. She has published widely in scholarly journals on a broad range of subjects related to health care, pharmaceuticals, biotechnology, insurance, and the economics of law.  She served as Section Editor on “The BioPharmaceutical and Medical Technology Industries” in Elsevier’s  Encyclopedia of Health Economics (2014) and co-edited the Handbook on the Economics of the Biopharmaceutical Industry (2012), for Oxford University Press. Recent publications include: “Affordability Challenges to Value-Based Pricing: Mass Diseases, Orphan Diseases, and Cures”. Value in Health 2017; “Pharmacy Benefit Management: Are Reporting Requirements Pro or Anti-Competitive?” International Journal of the Economics of Business 22(2) 2015:  245-261.